PB2019: PHASE 1B CLINICAL STUDY OF IRAK 1/4 INHIBITION FOR LOW-RISK MYELODYSPLASTIC SYNDROMES REFRACTORY/RESISTANT TO PRIOR THERAPIES: A TRIAL IN PROGRESS
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-08-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000974884.91552.90 |
| _version_ | 1797280129626406912 |
|---|---|
| author | Guillermo Garcia-Manero Lewis Silverman Lucy Yan Wolfgang Dummer |
| author_facet | Guillermo Garcia-Manero Lewis Silverman Lucy Yan Wolfgang Dummer |
| author_sort | Guillermo Garcia-Manero |
| collection | DOAJ |
| first_indexed | 2024-03-07T16:35:51Z |
| format | Article |
| id | doaj.art-d0013abee4ee441ab4e66a8ce60bf27a |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T16:35:51Z |
| publishDate | 2023-08-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-d0013abee4ee441ab4e66a8ce60bf27a2024-03-03T09:43:41ZengWileyHemaSphere2572-92412023-08-017e915529010.1097/01.HS9.0000974884.91552.90202308003-01895PB2019: PHASE 1B CLINICAL STUDY OF IRAK 1/4 INHIBITION FOR LOW-RISK MYELODYSPLASTIC SYNDROMES REFRACTORY/RESISTANT TO PRIOR THERAPIES: A TRIAL IN PROGRESSGuillermo Garcia-Manero0Lewis Silverman1Lucy Yan2Wolfgang Dummer31 University of Texas, MD Anderson Cancer Center, Department of Leukemia, Division of Cancer Medicine, Houston, United States2 Icahn School of Medicine at Mount Sinai (ISMMS) - The Derald H. Ruttenberg Treatment Center, Hematology-Oncology, New York City, United States3 Rigel Pharmaceuticals, Inc., South San Francisco, United States3 Rigel Pharmaceuticals, Inc., South San Francisco, United Stateshttp://journals.lww.com/10.1097/01.HS9.0000974884.91552.90 |
| spellingShingle | Guillermo Garcia-Manero Lewis Silverman Lucy Yan Wolfgang Dummer PB2019: PHASE 1B CLINICAL STUDY OF IRAK 1/4 INHIBITION FOR LOW-RISK MYELODYSPLASTIC SYNDROMES REFRACTORY/RESISTANT TO PRIOR THERAPIES: A TRIAL IN PROGRESS HemaSphere |
| title | PB2019: PHASE 1B CLINICAL STUDY OF IRAK 1/4 INHIBITION FOR LOW-RISK MYELODYSPLASTIC SYNDROMES REFRACTORY/RESISTANT TO PRIOR THERAPIES: A TRIAL IN PROGRESS |
| title_full | PB2019: PHASE 1B CLINICAL STUDY OF IRAK 1/4 INHIBITION FOR LOW-RISK MYELODYSPLASTIC SYNDROMES REFRACTORY/RESISTANT TO PRIOR THERAPIES: A TRIAL IN PROGRESS |
| title_fullStr | PB2019: PHASE 1B CLINICAL STUDY OF IRAK 1/4 INHIBITION FOR LOW-RISK MYELODYSPLASTIC SYNDROMES REFRACTORY/RESISTANT TO PRIOR THERAPIES: A TRIAL IN PROGRESS |
| title_full_unstemmed | PB2019: PHASE 1B CLINICAL STUDY OF IRAK 1/4 INHIBITION FOR LOW-RISK MYELODYSPLASTIC SYNDROMES REFRACTORY/RESISTANT TO PRIOR THERAPIES: A TRIAL IN PROGRESS |
| title_short | PB2019: PHASE 1B CLINICAL STUDY OF IRAK 1/4 INHIBITION FOR LOW-RISK MYELODYSPLASTIC SYNDROMES REFRACTORY/RESISTANT TO PRIOR THERAPIES: A TRIAL IN PROGRESS |
| title_sort | pb2019 phase 1b clinical study of irak 1 4 inhibition for low risk myelodysplastic syndromes refractory resistant to prior therapies a trial in progress |
| url | http://journals.lww.com/10.1097/01.HS9.0000974884.91552.90 |
| work_keys_str_mv | AT guillermogarciamanero pb2019phase1bclinicalstudyofirak14inhibitionforlowriskmyelodysplasticsyndromesrefractoryresistanttopriortherapiesatrialinprogress AT lewissilverman pb2019phase1bclinicalstudyofirak14inhibitionforlowriskmyelodysplasticsyndromesrefractoryresistanttopriortherapiesatrialinprogress AT lucyyan pb2019phase1bclinicalstudyofirak14inhibitionforlowriskmyelodysplasticsyndromesrefractoryresistanttopriortherapiesatrialinprogress AT wolfgangdummer pb2019phase1bclinicalstudyofirak14inhibitionforlowriskmyelodysplasticsyndromesrefractoryresistanttopriortherapiesatrialinprogress |